Scott Hensley
-
This is the first new drug approved for Alzheimer's disease since 2003. It's the first to show significant progress against the sticky brain plaques that are the hallmark of Alzheimer's disease. -
Updated study results say the vaccine is 76% effective against symptomatic COVID-19 and 100% effective against severe disease. Independent monitors had been concerned about a previous report.
-
The Food and Drug Administration typically follows the advice of its expert advisers. A quick agency decision on the Johnson & Johnson vaccine is expected given the state of the pandemic.
-
An FDA advisory panel meets to discuss emergency use approval of the coronavirus vaccine.
-
The president, who is being treated for COVID-19, has been downplaying the severity of the disease. He said falsely that, compared with the flu, COVID-19 is "in most populations far less lethal."
-
The president says 50,000 could die from the flu. So far this season, the Centers for Disease Control and Prevention says, it's at least 23,000 with an upper estimate as high as 59,000.
-
How do Americans experience and cope with pain that makes everyday life harder? We asked in the latest NPR-IBM Watson Health Poll.
-
The latest NPR-IBM Watson Health poll found that 29% of people said they were often angry when checking the news. Another 42% said the news sometimes made them angry.
-
The latest NPR-IBM Watson Health Poll finds that medical visits for symptoms of infections are common and that many people get an antibiotic under those circumstances. But a talk is in order first.
-
A third of people under 35 said cost led them to put off some form of health care, compared with only 8 percent of people 65 and older, a poll by NPR and IBM Watson Health found.
